Nigeria

Resilience System


You are here

AstraZeneca's COVID vaccine suffers a setback in nasal spray trial

Primary tabs

...

An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement on Tuesday.

...

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.521 seconds.